Research Studies
Back to Results
The ENCIRCLE high-risk trial: SAPIEN M3 system TransCatheter mitral valve ReplaCement vis TransseptaL AccEss
Primary Objective
To establish the safety and effectiveness of the SAPIEN M3 System in subjects with mitral regurgitation (MR) who are at high surgical riskv
Details
Age
Adult
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Treatment
Scope
National
Location
Medical Center of the Rockies
Principal Investigator
Brad Oldemeyer
Study ID
Protocol Number: 20-2889
More information available at ClinicalTrials.gov: NCT04153292
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers